TOCOX—A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk

✍ Scribed by Katie M. Groom; Andrew H. Shennan; Bryony A. Jones; Paul Seed; Phillip R. Bennett

• Book ID: 111161074
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 156 KB
• Volume: 112
• Category: Article
• ISSN: 1470-0328
• DOI: 10.1111/j.1471-0528.2005.00539.x